Abbott reported $11.22B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Agilent USD 1.48B 20M Jun/2026
AtriCure USD 76.13M 3.85M Sep/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.77B 407M Sep/2026
Bio-Rad Laboratories USD 441.8M 15.6M Jun/2026
Boston Scientific USD 3.05B 22M Jun/2026
Cooper Companies USD 788.9M 20.3M Jun/2026
Danaher USD 5.13B 163M Sep/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 937.8M 17.9M Sep/2026
Globus Medical USD 723.95M 15.33M Sep/2026
Insulet USD 689M 100.3M Sep/2026
Integra LifeSciences USD 248.99M 18.19M Sep/2026
Intuitive Surgical USD 1.72B 48.1M Sep/2026
J&J USD 19.05B 3.49B Jun/2026
Medtronic USD 6.36B 286M Jun/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Pfizer USD 17.57B 1.38B Sep/2026
Smith & Nephew USD 1.52B 36M Jun/2026
Solventum Corp USD 1.39B 302M Sep/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 180.02M 17.96M Sep/2026
Teleflex USD 379.64M 15.03M Sep/2026
Terumo JPY 208.1B 17.47B Sep/2026
Thermo Fisher Scientific USD 9.62B 174M Sep/2026
Zimmer Biomet Holdings USD 1.82B 46.5M Sep/2026